Clinical trial · Interventional
Aerobic and Strengthening Exercise for Acute Leukemia
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Survivors of childhood leukemia have muscle weakness and impaired mobility (physical performance), a higher than expected frequency of obesity, and early mortality from cardiovascular disease. Treatment related neuropathy, cardiotoxicity and general cachexia may complicate physical performance and establish a pattern of sedentary behavior that may lead to a lifetime of inactivity. There is limited evidence that children being treated for leukemia benefit from home exercise programs during the maintenance phase of therapy, particularly in terms of muscle strength and range of motion. However, there are no established guidelines regarding the prescription of exercise for children diagnosed with leukemia. We propose to test the feasibility of an exercise intervention among children being treated for acute lymphoblastic leukemia (ALL) and hypothesize that children who participate in the exercise intervention will demonstrate improvements in gross motor function, strength, flexibility, and cardio respiratory fitness, and that they will have more favorable body composition when compared to the children who are assigned to the usual activity group.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (7)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Aerobic capacity | Other | — | UNRESOLVED |
| Ankle range of motion | Other | — | UNRESOLVED |
| Body composition and vital signs | Other | — | UNRESOLVED |
| Flexibility | Other | — | UNRESOLVED |
| Gross Motor Function | Other | — | UNRESOLVED |
| Hand grip strength | Other | — | UNRESOLVED |
| Knee extension strength | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- 1
- description
- This single-arm feasibility trial will evaluate the administration of an aggressive exercise regimen.
- interventionNames
- Other: Gross Motor Function
- Other: Knee extension strength
- Other: Hand grip strength
- Other: Flexibility
- Other: Ankle range of motion
- Other: Aerobic capacity
- Other: Body composition and vital signs
Primary outcomes (1)
- measure
- To determine the feasibility of an aerobic and strengthening exercise intervention trial among children during maintenance therapy for childhood ALL by evaluating participant accrual, participant compliance and burden to institutional staff.
- timeFrame
- 1 year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 5 Years
- Maximum age
- 10 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosed with childhood ALL when age greater than 1 and less than 10 at diagnosis, white blood cell count less than 50,000 cells/microliter and receiving continuation/maintenance therapy based on the original disease classification * In first remission * Maintenance phase of therapy (Eligibility extends from Day 0 of maintenance therapy up to six months prior to the completion of therapy) * Current age 5-10 years * Modified Lansky performance scale must score 60 or higher at time of enrollment * Written informed consent Exclusion Criteria: * Lower extremity amputation or congenital deformity of lower limb * History of pre-existing neuron-motor or neuro-developmental disorder prior to diagnosis of childhood ALL, such as mental retardation, Down syndrome, cerebral palsy, and traumatic brain injury * Pre-existing heart or lung disease by clinical history * Children with specific contraindications to exercise will be offered enrollment after this transient condition is resolved: severe anemia (Hemoglobin less than 8 g/dl), fever greater than 38 degrees Centigrade, platelets less than 50\*109/ul, neutrophil counts less than 0.5\*109/ul.
References
Publications (0)
Data not yet available